别名 Deficiency of iduronate-2-sulfatase、Deficiency of iduronate-2-sulphatase、Deficiency, I2S + [87] |
简介 Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15. |
作用机制 IDS stimulators [+1] |
在研适应症 |
非在研适应症- |
最高研发阶段批准上市 |
首次获批国家/地区 日本 |
首次获批日期2021-03-23 |
靶点 |
作用机制 GAG调节剂 |
非在研适应症- |
最高研发阶段批准上市 |
首次获批国家/地区 韩国 |
首次获批日期2012-01-09 |
开始日期2024-04-10 |
开始日期2024-04-10 |
申办/合作机构 |
开始日期2024-03-05 |